C. R. Abraham, D. J. Selkoe, and H. Potter, Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease, Cell, vol.52, 1988.

M. Anheim, Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.12, p.78, 2007.
DOI : 10.1136/jnnp.2007.123026

G. J. Annas, Privacy rules for DNA databanks. Protecting coded 'future diaries', JAMA: The Journal of the American Medical Association, vol.270, issue.19, 1993.
DOI : 10.1001/jama.270.19.2346

J. A. Armour, C. Sismani, P. C. Patsalis, and G. Cross, Measurement of locus copy number by hybridisation with amplifiable probes, Nucleic acids research 28, 2000.
DOI : 10.1093/nar/28.2.605

L. Bertram and R. E. Tanzi, Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses, Nature Reviews Neuroscience, vol.55, issue.10, 2008.
DOI : 10.1097/00001756-199309000-00015

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathologica, vol.80, issue.4, 1991.
DOI : 10.1007/BF00308809

J. P. Brion, A. M. Couck, E. Passareiro, and J. Flament-durand, Neurofibrillary Tangles and Alzheimer???s Disease, European Neurology, vol.40, issue.3, 1985.
DOI : 10.1159/000007969

J. D. Buxbaum, Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene, Molecular Psychiatry, vol.388, issue.2, 2008.
DOI : 10.1016/j.biopsych.2005.11.028

L. Cabrejo, Phenotype associated with APP duplication in five families, Brain, vol.129, issue.11, 2006.
DOI : 10.1093/brain/awl237
URL : https://hal.archives-ouvertes.fr/hal-00170801

D. Campion, Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum, The American Journal of Human Genetics, vol.65, issue.3, 1999.
DOI : 10.1086/302553
URL : http://doi.org/10.1086/302553

A. Capell, Maturation and pro-peptide cleavage of beta-secretase, The Journal of biological chemistry, vol.275, 2000.

M. M. Carrasquillo, Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, A??, and Alzheimer's Disease, PLoS ONE, vol.5, issue.1, p.8764, 2010.
DOI : 10.1371/journal.pone.0008764.s007

M. M. Carrasquillo, Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease, Archives of Neurology, vol.67, issue.8, 2010.
DOI : 10.1001/archneurol.2010.147

F. Casilli, Rapid detection of novel BRCA1 rearrangements in high-risk breastovarian cancer families using multiplex PCR of short fluorescent fragments, Human, vol.20, 2002.

T. Caspersson, Chemical differentiation along metaphase chromosomes. Experimental cell research 49, 1968.
DOI : 10.1016/0014-4827(68)90538-7

A. M. Cataldo, Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome, Neurobiology of aging, vol.25, 2004.

F. Charbonnier, Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments, Cancer, vol.60, 2000.

A. R. Chaudhury, Neuregulin-1 and ErbB4 Immunoreactivity Is Associated with Neuritic Plaques in Alzheimer Disease Brain and in a Transgenic Model of Alzheimer Disease, Journal of Neuropathology & Experimental Neurology, vol.62, issue.1, 2003.
DOI : 10.1093/jnen/62.1.42

E. T. Cirulli and D. B. Goldstein, Uncovering the roles of rare variants in common disease through whole-genome sequencing, Nature Reviews Genetics, vol.39, issue.6, 2010.
DOI : 10.1038/nrg2779

D. F. Conrad, Origins and functional impact of copy number variation in the human genome, Nature, vol.36, issue.7289, 2010.
DOI : 10.1038/nature08516

G. M. Cooper, A copy number variation morbidity map of developmental delay, Nature Genetics, vol.455, issue.9, 2011.
DOI : 10.1038/nature05329

J. J. Corneveaux, Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals, Human Molecular Genetics, vol.19, issue.16, 2010.
DOI : 10.1093/hmg/ddq221

M. J. De-leon, Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease, Neurobiology of Aging, vol.18, issue.1, 1997.
DOI : 10.1016/S0197-4580(96)00213-8

L. C. De-souza, Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.3, p.82, 2011.
DOI : 10.1136/jnnp.2010.207183

B. De-strooper, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature, vol.391, 1998.

A. Delacourte, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, Neurology, vol.52, issue.6, 1999.
DOI : 10.1212/WNL.52.6.1158

A. Deshpande, H. Kawai, R. Metherate, C. G. Glabe, and J. Busciglio, A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.29, 2009.

D. Fede and G. , A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis, Science, vol.323, issue.5920, 2009.
DOI : 10.1126/science.1168979

B. Dubois, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, 2007.
DOI : 10.1016/S1474-4422(07)70178-3

B. Dubois, Revising the definition of Alzheimer's disease: a new lexicon, The Lancet Neurology, vol.9, issue.11, 2010.
DOI : 10.1016/S1474-4422(10)70223-4

A. Duclos, Pitfalls in the use of DGV for CNV interpretation, American Journal of Medical Genetics Part A, vol.122, issue.10, 2011.
DOI : 10.1002/ajmg.a.34195

C. Dumanchin, Segregation of a Missense Mutation in the Microtubule-Associated Protein Tau Gene with Familial Frontotemporal Dementia and Parkinsonism, Human Molecular Genetics, vol.7, issue.11, 1998.
DOI : 10.1093/hmg/7.11.1825

C. Dumanchin, Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques, Human Mutation, vol.27, issue.10, 2006.
DOI : 10.1002/humu.9458

C. Duyckaerts, Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories A European multicenter study under the auspices of EURAGE, Journal of the Neurological Sciences, vol.97, issue.2-3, 1990.
DOI : 10.1016/0022-510X(90)90226-D

E. Engidawork and G. Lubec, Protein expression in Down syndrome brain, Amino Acids, vol.21, issue.4, 2001.
DOI : 10.1007/s007260170001

L. Feuk, A. R. Carson, and S. W. Scherer, Structural variation in the human genome, Nature Reviews Genetics, vol.37, issue.2, 2006.
DOI : 10.1038/nrg1767

V. H. Finder and R. Glockshuber, Amyloid-beta aggregation, Neuro-degenerative diseases, vol.4, 2007.

R. Francis, aph-1 and pen-2 are required for Notch pathway signaling, gammasecretase cleavage of betaAPP, and presenilin protein accumulation, Developmental, vol.3, 2002.

A. L. Friedlich, Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease, Journal of Neuroscience, vol.24, issue.13, 2004.
DOI : 10.1523/JNEUROSCI.0297-04.2004

E. Genin, APOE and Alzheimer disease: a major gene with semi-dominant inheritance, Molecular Psychiatry, vol.67, issue.9, 2011.
DOI : 10.1056/NEJMoa0809578
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162068

P. H. George-hyslop, The genetic defect causing familial Alzheimer's disease maps on chromosome 21, Science, vol.235, issue.4791, p.235, 1987.
DOI : 10.1126/science.2880399

G. G. Glenner and C. W. Wong, Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochemical and Biophysical Research Communications, vol.120, issue.3, 1984.
DOI : 10.1016/S0006-291X(84)80190-4

A. Goate, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, vol.349, 1991.

C. Goutte, M. Tsunozaki, V. A. Hale, and J. Priess, APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos, Proceedings of the National Academy of Sciences of the United States of America 99, 2002.
DOI : 10.1073/pnas.022523499

A. Guilmatre, Recurrent Rearrangements in Synaptic and Neurodevelopmental Genes and Shared Biologic Pathways in Schizophrenia, Autism, and Mental Retardation, Archives of General Psychiatry, vol.66, issue.9, 2009.
DOI : 10.1001/archgenpsychiatry.2009.80
URL : https://hal.archives-ouvertes.fr/inserm-00417413

I. Guyant-marechal, INTRAFAMILIAL DIVERSITY OF PHENOTYPE ASSOCIATED WITH APP DUPLICATION, Neurology, vol.71, issue.23, 2008.
DOI : 10.1212/01.wnl.0000339400.64213.56
URL : https://hal.archives-ouvertes.fr/hal-00482227

J. Hardy and D. J. Selkoe, The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics, Science, vol.297, issue.5580, p.297, 2002.
DOI : 10.1126/science.1072994

J. A. Hardy and G. A. Higgins, Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, issue.5054, p.256, 1992.
DOI : 10.1126/science.1566067

J. Hardy, The Alzheimer family of diseases: Many etiologies, one pathogenesis?, Proceedings of the National Academy of Sciences, vol.94, issue.6, 1997.
DOI : 10.1073/pnas.94.6.2095

D. Harold, Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, Nature genetics, p.41, 2009.

E. L. Heinzen, Genome-wide scan of copy number variation in late-onset Alzheimer's disease, Journal of Alzheimer's disease : JAD, vol.19, 2010.

D. Hirtz, How common are the "common" neurologic disorders?, Neurology, vol.68, issue.5, 2007.
DOI : 10.1212/01.wnl.0000252807.38124.a3

D. M. Holtzman, In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology, Journal of molecular neuroscience : MN, vol.23, 2004.

Y. Hu, Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients, Neuroscience Letters, vol.320, issue.3, 2002.
DOI : 10.1016/S0304-3940(02)00047-2

P. Iribarren, Y. Zhou, J. Hu, L. Yingying, &. Wang et al., Role of Formyl Peptide Receptor???Like 1 (FPRL1/FPR2) in Mononuclear Phagocyte Responses in Alzheimer Disease, Immunologic Research, vol.31, issue.3, p.31, 2005.
DOI : 10.1385/IR:31:3:165

A. Itsara, Population analysis of large copy number variants and hotspots of human genetic disease, American journal of human genetics, vol.84, 2009.

C. R. Jack and . Jr, Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia, Neurology, vol.58, issue.5, 2002.
DOI : 10.1212/WNL.58.5.750

J. , P. A. Strong, and J. A. , A case of human intersexuality having a possible XXY sex-determining mechanism, Nature, vol.183, 1959.

S. Jacquemont, Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus, Nature, vol.296, issue.7367, 2011.
DOI : 10.1038/nature10406
URL : https://hal.archives-ouvertes.fr/inserm-00619240

L. B. Jaeger, Testing the neurovascular hypothesis of Alzheimer's disease, p.1

J. T. Jarrett, E. P. Berger, and P. T. Lansbury, Jr The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease, Biochemistry, vol.32, 1993.

K. A. Jellinger, Traumatic brain injury as a risk factor for Alzheimer's disease, Journal of neurology, p.75, 2004.

G. Jun, Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes, Archives of Neurology, vol.67, issue.12, 2010.
DOI : 10.1001/archneurol.2010.201

A. Kallioniemi, Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors, Science, vol.258, issue.5083, p.258, 1992.
DOI : 10.1126/science.1359641

R. Karlsson, MAGI1 Copy Number Variation in Bipolar Affective Disorder and Schizophrenia, Biological Psychiatry, vol.71, issue.10, 2012.
DOI : 10.1016/j.biopsych.2012.01.020

H. Karlstrom, Variable phenotype of Alzheimer's disease with spastic paraparesis, Journal of neurochemistry, vol.104, 2008.

J. Kim, J. M. Basak, and D. M. Holtzman, The Role of Apolipoprotein E in Alzheimer's Disease, Neuron, vol.63, issue.3, 2009.
DOI : 10.1016/j.neuron.2009.06.026

P. M. Kim, J. O. Korbel, and M. B. Gerstein, Positive selection at the protein network periphery: Evaluation in terms of structural constraints and cellular context, Proceedings of the National Academy of Sciences, vol.104, issue.51, 2007.
DOI : 10.1073/pnas.0710183104

E. Klopocki, Complex Inheritance Pattern Resembling Autosomal Recessive Inheritance Involving a Microdeletion in Thrombocytopenia???Absent Radius Syndrome, The American Journal of Human Genetics, vol.80, issue.2, 2007.
DOI : 10.1086/510919

D. S. Knopman, Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, vol.56, issue.9, 2001.
DOI : 10.1212/WNL.56.9.1143

A. D. Koolen, Clinical and molecular delineation of the 17q21.31 microdeletion syndrome, Journal of Medical Genetics, vol.45, issue.11, 2008.
DOI : 10.1136/jmg.2008.058701

T. Kudo, Are cerebrovascular factors involved in Alzheimer's disease? Neurobiology of aging 21, 2000.

S. Kumar-singh, Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40, Human mutation, p.27, 2006.

J. Lambert, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nature Genetics, vol.12, issue.10, p.41, 2009.
DOI : 10.1038/ng.439

D. Langui, Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. The American journal of pathology 165, 2004.

E. Levy-lahad, Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science, vol.269, issue.5226, p.269, 1995.
DOI : 10.1126/science.7638622

X. Lin, Human aspartic protease memapsin 2 cleaves the beta -secretase site of beta -amyloid precursor protein, Proceedings of the National Academy of Sciences of the United States of America 97, 2000.
DOI : 10.1073/pnas.97.4.1456

S. P. Little, Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer's Disease Brain, Journal of Biological Chemistry, vol.272, issue.40, 1997.
DOI : 10.1074/jbc.272.40.25135

K. E. Lohmueller, Proportionally more deleterious genetic variation in European than in African populations, Nature, vol.101, issue.7181, 2008.
DOI : 10.1038/nature06611
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923434

O. L. Lopez, Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease, Neurology, vol.40, issue.10, 1990.
DOI : 10.1212/WNL.40.10.1517

W. Luo, PEN-2 and APH-1 Coordinately Regulate Proteolytic Processing of Presenilin 1, Journal of Biological Chemistry, vol.278, issue.10, 2003.
DOI : 10.1074/jbc.C200648200

J. Lupski, Genome structural variation and sporadic disease traits, Nature Genetics, vol.38, issue.9, 2006.
DOI : 10.1126/science.1090278

V. Malan and S. Romana, Diagnosis of chromosomal abnormalities by array CGH in constitutional pathology: the end of the first-line karyotype], Arch Pediatr, vol.19, 2012.

R. A. Marr, Neprilysin regulates amyloid Beta peptide levels, Journal of molecular neuroscience : MN, vol.22, 2004.
DOI : 10.1385/jmn:22:1-2:5

S. A. Mccarroll, Integrated detection and population-genetic analysis of SNPs and copy number variation, Nature Genetics, vol.40, issue.10, p.40, 2008.
DOI : 10.1126/science.1099870

G. Mckhann, Clinical diagnosis of Alzheimer " s disease: report of the NINCDS- ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, 1984.

D. Mcnaughton, Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series, Neurobiology of Aging, vol.33, issue.2, 2012.
DOI : 10.1016/j.neurobiolaging.2010.10.010

D. T. Miller, Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies, The American Journal of Human Genetics, vol.86, issue.5
DOI : 10.1016/j.ajhg.2010.04.006

K. Morgan, The three new pathways leading to Alzheimer's disease, Neuropathology and Applied Neurobiology, vol.5, issue.4, 2011.
DOI : 10.1111/j.1365-2990.2011.01181.x

R. Motter, Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease, Annals of neurology, vol.38, 1995.

P. C. Ng, Genetic Variation in an Individual Human Exome, PLoS Genetics, vol.445, issue.8, 2008.
DOI : 10.1371/journal.pgen.1000160.s013

N. , P. C. Hungerford, and D. A. , Chromosome studies on normal and leukemic human leukocytes, Journal of the National Cancer Institute, vol.25, 1960.

K. Ogawa, Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease, Psychiatry and Clinical Neurosciences, vol.64, issue.4, 2000.
DOI : 10.1016/S0167-4838(97)00094-0

D. P. Perl, NEUROPATHOLOGY OF ALZHEIMER'S DISEASE AND RELATED DISORDERS, Neurologic Clinics, vol.18, issue.4, 2000.
DOI : 10.1016/S0733-8619(05)70229-2

D. Pinkel, High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays, Nature, vol.20, 1998.

T. M. Polvikoski, Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old, Neurology, vol.75, issue.23, 2010.
DOI : 10.1212/WNL.0b013e318200d6f9

C. Pottier, Amyloid-protein precursor gene expression in alzheimer's disease and other conditions, Journal of Alzheimer's disease : JAD, vol.28, 2012.

C. Pottier, High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease, Molecular Psychiatry, vol.17, issue.9, 2012.
DOI : 10.1093/hmg/ddq390
URL : https://hal.archives-ouvertes.fr/hal-00965204

S. I. Rapoport, Integrated phylogeny of the primate brain, with special reference to humans and their diseases. Brain research, Brain research reviews, vol.15, 1990.

R. Redon, Global variation in copy number in the human genome, Nature, vol.38, issue.7118, 2006.
DOI : 10.1126/science.1117196

C. Reitz, Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease, Archives of Neurology, vol.68, issue.1, 2011.
DOI : 10.1001/archneurol.2010.346

E. I. Rogaev, Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer " s disease type 3 gene, Nature, vol.376, 1995.

E. Rogaeva, The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease, Nature Genetics, vol.279, issue.2, 2007.
DOI : 10.1038/ng1943

E. Rogaeva, T. Kawarai, and P. S. George-hyslop, Genetic complexity of Alzheimer's disease: successes and challenges, Journal of Alzheimer's disease, issue.9, 2006.

J. Rogers, Peripheral clearance of amyloid beta peptide by complement C3- dependent adherence to erythrocytes, Neurobiology of aging, vol.27, 2006.

A. Rovelet-lecrux, A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease, European Journal of Human Genetics, vol.172, issue.6, 2012.
DOI : 10.1038/nrg2779
URL : https://hal.archives-ouvertes.fr/hal-00965208

A. Rovelet-lecrux, APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nature Genetics, vol.302, issue.1, 2006.
DOI : 10.1038/ng1718

A. Rovelet-lecrux, Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease, Neurobiology of Disease, vol.31, issue.1, p.31, 2008.
DOI : 10.1016/j.nbd.2008.03.004

A. Rovelet-lecrux, Partial deletion of the MAPT gene: a novel mechanism of FTDP-17, Human, vol.30, 2009.

A. Salminen, J. Ojala, T. Suuronen, K. Kaarniranta, and A. Kauppinen, Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology, Journal of cellular and molecular medicine, vol.12, 2008.
DOI : 10.1111/j.1582-4934.2008.00496.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514104

P. Saugier-veber, Detection of heterozygous SMN1 deletions in SMA families using a simple fluorescent multiplex PCR method, Journal of Medical Genetics, vol.38, issue.4, 2001.
DOI : 10.1136/jmg.38.4.240

G. D. Schellenberg, Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14, Science, vol.258, issue.5082, p.258, 1992.
DOI : 10.1126/science.1411576

D. E. Schmechel, Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease., Proceedings of the National Academy of Sciences of the United States of America 90, 1993.
DOI : 10.1073/pnas.90.20.9649

J. P. Schouten, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Research, vol.30, issue.12, 2002.
DOI : 10.1093/nar/gnf056

J. Sebat, Large-Scale Copy Number Polymorphism in the Human Genome, Science, vol.305, issue.5683, p.305, 2004.
DOI : 10.1126/science.1098918

D. J. Selkoe, Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease, Current opinion in neurobiology, vol.4, 1994.

S. Shah, Nicastrin functions as a gamma-secretase-substrate receptor, Cell, vol.122, 2005.
DOI : 10.1016/j.cell.2005.05.022
URL : http://doi.org/10.1016/j.cell.2005.05.022

G. M. Shankar, Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.27, 2007.

A. J. Sharp, A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures, Nature Genetics, vol.143, issue.3, 2008.
DOI : 10.1006/meth.2001.1262

R. Sherrington, Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant, Human Molecular Genetics, vol.5, issue.7, 1996.
DOI : 10.1093/hmg/5.7.985

R. Sherrington, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, vol.375, issue.6534, 1995.
DOI : 10.1038/375754a0

H. Shiraishi, PEN-2 enhances gamma-cleavage after presenilin heterodimer formation, Journal of Neurochemistry, vol.90, issue.6, 2004.
DOI : 10.1111/j.1471-4159.2004.02597.x

K. Sleegers, APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy, Brain, vol.129, issue.11, 2006.
DOI : 10.1093/brain/awl203

H. Steiner, A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques, The Journal of biological chemistry, vol.276, 2001.

P. Sudmant, Diversity of Human Copy Number Variation and Multicopy Genes, Science, vol.330, issue.6004, 2010.
DOI : 10.1126/science.1197005

S. Swaminathan, Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study, International Journal of Alzheimer's Disease, vol.176, issue.7, p.729478, 2011.
DOI : 10.1093/nar/gkq040

T. Tabira, H. De-chui, H. Nakayama, S. Kuroda, and M. Shibuya, Alzheimer's disease with spastic paresis and cotton wool type plaques, Journal of Neuroscience Research, vol.54, issue.3, 2002.
DOI : 10.1002/jnr.10392

R. E. Tanzi, Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science, vol.235, issue.4791, p.235, 1987.
DOI : 10.1126/science.2949367

E. Thornton, R. Vink, P. C. Blumbergs, and C. Van-den-heuvel, Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats, Brain, vol.1094, 2006.

H. L. Tiffany, Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain, The Journal of biological chemistry, vol.276, 2001.

A. Tolia and B. De-strooper, Structure and function of gamma-secretase. Seminars in cell developmental biology 20, 2009.

K. Uéda, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease., Proceedings of the National Academy of Sciences of the United States of America 90, 1993.
DOI : 10.1073/pnas.90.23.11282

P. G. Vallet, A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease, Acta Neuropathologica, vol.12, issue.2, 1992.
DOI : 10.1007/BF00308476

M. Vandermeeren, Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay, Journal of neurochemistry, p.61, 1993.

R. Vassar, Beta-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE, Science, vol.286, issue.5440, p.286, 1999.
DOI : 10.1126/science.286.5440.735

S. Vepsäläinen, Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology, Neuroscience letters, p.438, 2008.

S. Vepsäläinen, Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population, Journal of Medical Genetics, vol.44, issue.9, 2007.
DOI : 10.1136/jmg.2006.048470

K. S. Vetrivel and G. Thinakaran, Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments, Neurology, vol.66, 2006.

P. J. Visser, P. Scheltens, E. Pelgrim, and F. Verhey, Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients. Dementia and geriatric cognitive disorders 19, 2005.

D. Wallon, The French Series of Autosomal Dominant Early Onset Alzheimer's Disease Cases: Mutation Spectrum and Cerebrospinal Fluid Biomarkers, Journal of Alzheimer's disease, p.JAD, 2012.

R. G. Walters, A new highly penetrant form of obesity due to deletions on chromosome 16p11.2, Nature, vol.30, issue.7281, 2010.
DOI : 10.1038/nature08727

P. J. Whitehouse, D. L. Price, A. W. Clark, J. T. Coyle, and M. R. Delong, Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis, Annals of Neurology, vol.1, issue.2, 1981.
DOI : 10.1002/ana.410100203

M. S. Wolfe, When loss is gain: reduced presenilin proteolytic function leads to increased A??42/A??40. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO reports, vol.2, issue.2, 2007.
DOI : 10.1038/sj.embor.7400896

Z. Wu, Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease, Nature Medicine, vol.104, 2005.
DOI : 10.1016/S0165-0270(03)00206-1

R. Yan, Membrane-anchored aspartyl protease with Alzheimer's disease betasecretase activity, Nature, vol.402, 1999.

G. Ying, Humanin, a newly identified neuroprotective factor, uses the G proteincoupled formylpeptide receptor-like-1 as a functional receptor, Journal of immunology, vol.172, 2004.

G. Yu, Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing, Nature, vol.407, 2000.

C. Zekanowski, Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: Genetic and bioinformatic assessment, Experimental Neurology, vol.200, issue.1, 2006.
DOI : 10.1016/j.expneurol.2006.01.022

F. Zeng, Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients, Human Mutation, vol.47, issue.1, 2008.
DOI : 10.1002/humu.20613

F. Zhang, Copy Number Variation in Human Health, Disease, and Evolution, Annual Review of Genomics and Human Genetics, vol.10, issue.1, 2009.
DOI : 10.1146/annurev.genom.9.081307.164217